Ron Firestein, MD, PhD
Associate Professor Ron Firestein is the Head of the Cancer Centre at the Hudson Institute of Medical Research and Head of Research for the Hudson Monash Paediatric Precision Medicine Program. A/Prof Firestein is a physician scientist double board certified in Pathology (Anatomic and Molecular Genet
Jason Cain, PhD
Dr. Jason Cain is Head of the Developmental and Cancer Biology research group in Hudson Institute’s Centre for Cancer Research and a Chief Investigator for the Hudson Monash Paediatric Precision Medicine Program. A developmental and cancer biologist, Dr. Cain is driving cutting-edge research to unde
A global bioscience medical research leader, Hudson Institute’s sole focus is on powering breakthrough scientific discoveries into improved healthcare that will transform lives. Our 442 scientists research four areas of medical need - inflammation, cancer, reproductive health and pregnancy, and infant and child health.
The Hudson Monash Paediatric Precision Medicine (HMPPM) Program hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours.
Clinical experience based on patient need informs Hudson Institute’s research enquiry, and our close ties with medical staff and industry support the translation of our discoveries into new preventative approaches, therapies and devices for patients.
Hudson Institute is located within a major scientific research and medical innovation hub in Melbourne’s south-eastern corridor. With our precinct partners, Monash Health and Monash University, we deliver outstanding healthcare, education and leading research.
Caroline Drinkwater | Clinical Research Coordinatorhttps://hudson.org.au/
Caroline Drinkwater, BBiomedSc
Caroline Drinkwater is the Australian Lions Childhood Cancer Research Foundation (ALCCRF) Senior Biobank Specialist for the Hudson Monash Paediatric Precision Medicine (HMPPM) Program.In the collaborative HMPPM Program, scientists at Hudson Institute have established a ‘Living Biobank’ of childhood
Claire Sun, PhD
Dr Sun’s previous research, which highlights the importance of bioinformatics in understanding tumorigenesis and aiding in the development of precision medicines, has redefined her new interest in translating basic research findings into clinical applications using the most cutting edge bioinformati
Daniel Gough, PhD
After completing his BSc (2000) and BSc (Hons) (2001) in the Department of Pathology at the University of Melbourne, and PhD (2006) at the Peter MacCallum Cancer Centre, Dr. Gough moved to New York University in the USA for postdoctoral training with Professor David E Levy (Dr. Louis A. Schneider Pr